| LocationOctreoPharm Sciences GmbH is located in the historical building # B55 (4th floor) of "Oscar-Cecilie-Vogt Haus" of the campus. Medical-biological research has a 75-year tradition in this building. Here in 1930 the Institute for Brain Research of the Kaiser-Wilhelm-Research-Association (now: Max-Planck-Gesellschaft) with the affiliated neurological clinic was established, with Professor Oskar Vogt as director. At that time the institute was the largest and most modern of its kind in the world. Vogt's work focused on histological-anatomic and functional layer- and field structures (topistic) of the cerebral cortex. From 1937 on, Vogt's successor directed the institute's research onto various neuropathological problems including brain tumors. The institute achieved special renown through the work of the Russian geneticist Professor N.W. Timoféeff-Ressovsky on gene mutations and the structure of the gene, in part together with Professor Max Delbrueck.
From 1939/40 on, the brains from victims who had been killed as part of the Nazi euthanasia program, and also war victims, were used for research purposes at the Kaiser Wilhelm Institute of Brain Research. A memorial on the Campus commemorates the victims and serves as a warning for future generations.
In 1947 the institute and clinic were combined as the Institute for Medicine and Biology and placed under the auspices of the German Academy of Sciences in Berlin. The institute became a well-known center for cancer research with research projects on the chemical genesis of cancer, oncogenic viruses, biochemistry, immunology, genetics and radiobiology as well as the clinical treatment of tumors. In 1972 the different Academy research institutes at Berlin-Buch merged to form the central institutes for molecular biology and for cancer research.
With the unification of West and East Germany in 1990, the academy institutes were phased out in accordance with the unification agreement. Subsequently, the Max Delbrueck Center for Molecular Medicine (MDC) Berlin-Buch was founded on the Campus in 1992. Starting in 1995, biotechnology companies have settled on the Campus in the Innovation and Founding Center. In 2000 the Leibniz Institute for Molecular Pharmacology was established. These four together - basic research, the clinics, established biotechnology companies and biopharmaceutical start-up companies make the Biomedical Research Campus Berlin-Buch one of the leading institutions of its kind in Germany.
For further information, refer to: "Geschichte der medizinisch-biologischen Institute Berlin-Buch / Professor Heinz Bielka / ISBN 3-540-42842-9". |
